EGFR has been shown to initiate multistage skin carcinogenesis in murine models through activation of STAT3 [52] and ErbB2 and EGFR family receptors have been demonstrated to be frequently amplified in squamous cell carcinoma of uterine cervix [53,54]. The gene discussed is STAT3; the disease is squamous cell carcinoma.